Hyperbaric oxygen as a treatment for COVID-19 infection?
dc.contributor.author | Moon, Richard E | |
dc.contributor.author | Weaver, Lindell K | |
dc.date.accessioned | 2021-01-05T01:35:04Z | |
dc.date.available | 2021-01-05T01:35:04Z | |
dc.date.issued | 2020-01 | |
dc.date.updated | 2021-01-05T01:35:02Z | |
dc.description.abstract | Recently the internet has been abuzz with new ideas to treat COVID-19, including hyperbaric oxygen (HBO2) therapy, undoubtedly driven by the fact that until recently there have been few therapeutic options for this highly contagious and often lethal infection. . . . Refractory hypoxemia is certainly treatable with hyperbaric oxygen due to the obvious effect of increasing inspired oxygen partial pressure (PO2), the major reason for using HBO2 for its established indications. However, the length of time during which patients can safely be administered HBO2 inside a chamber is limited, due to practical issues of confinement and isolation from other necessary medical interventions, but also because of oxygen toxicity. | |
dc.identifier.issn | 1066-2936 | |
dc.identifier.uri | ||
dc.language | eng | |
dc.relation.ispartof | Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc | |
dc.subject | Humans | |
dc.subject | Pneumonia, Viral | |
dc.subject | Coronavirus Infections | |
dc.subject | Oxygen | |
dc.subject | Pulmonary Gas Exchange | |
dc.subject | Hyperbaric Oxygenation | |
dc.subject | Middle Aged | |
dc.subject | Male | |
dc.subject | Pandemics | |
dc.subject | Hypoxia | |
dc.subject | Betacoronavirus | |
dc.subject | COVID-19 | |
dc.subject | SARS-CoV-2 | |
dc.title | Hyperbaric oxygen as a treatment for COVID-19 infection? | |
dc.type | Journal article | |
duke.contributor.orcid | Moon, Richard E|0000-0003-4432-0332 | |
pubs.begin-page | 177 | |
pubs.end-page | 179 | |
pubs.issue | 2 | |
pubs.organisational-group | School of Medicine | |
pubs.organisational-group | Medicine, Pulmonary, Allergy, and Critical Care Medicine | |
pubs.organisational-group | Anesthesiology, General, Vascular, High Risk Transplant & Critical Care | |
pubs.organisational-group | Duke | |
pubs.organisational-group | Medicine | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Anesthesiology | |
pubs.publication-status | Published | |
pubs.volume | 47 |
Files
Original bundle
- Name:
- Final Published Version 8-4-2020.pdf
- Size:
- 479.99 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version